Jw Therapeutics

Developer of cell immunotherapy products for cancer treatment

placeShanghai, Shanghai, China calendar_todayFounded 2016 groups490 employees language jwtherapeutics.com

Social engagement

Social engagement: 2K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

18 investors on record; lead investors include Temasek, Sequoia Capital, Yuan Ming Capital, Yuanhe Holdings.

Investor typeCountShare
Venture capital422%
Private equity528%
Bank & private debt16%
Other / undisclosed844%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

24 Mar 2026 · BD Director

Based on job postings tracked across public sources.

Recent activity

5 Dec 2025
Event
ASH Annual Meeting and Exposition 2026
3 Dec 2025
Partnership
JW Therapeutics
3 Dec 2025
Partnership
Renneron
Coming soon